JNJ
Johnson & Johnson
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Johnson & Johnson (JNJ), founded in 1886, is a premier American multinational corporation at the forefront of the global healthcare sector, acclaimed for its diversified product offerings in pharmaceuticals, medical devices, and consumer health products. With an unwavering commitment to innovation a...
$234.18
-0.15% ($0.36)
Volume
8.83M
52W High
$251.71
52W Low
$142.93
Market Cap
$578.22B
What to Watch This Quarter
Based on historical dataConsensus EPS
$2.84
Whisper EPS
$2.84
0.0% below consensus
Last Quarter
$2.14
Current Streak
1 Miss
Avg Surprise (4Q)
-2.86%
Next Earnings Report
Reports in 86 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Apr 14, 2026
1-Day:
-0.60%
Q4 2025
Jan 21, 2026
1-Day:
+0.22%
5-Day:
+1.60%
Q3 2025
Oct 14, 2025
1-Day:
+0.17%
Q2 2025
Jul 16, 2025
1-Day:
-1.09%
5-Day:
-0.25%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $24.56B | +9.1% | 86.4% | 22.0% | $5.12B |
| Q3'25 | $23.99B | +6.8% | 69.6% | 29.6% | $5.15B |
| Q2'25 | $23.74B | +5.8% | 67.9% | 28.7% | $5.54B |
| Q1'25 | $21.89B | +2.4% | 66.4% | 28.8% | $11.00B |
| Q4'24 | $22.52B | +5.3% | 68.4% | 17.1% | $3.43B |
| Q3'24 | $22.47B | +5.3% | 69.0% | 23.5% | $2.69B |
| Q2'24 | $22.45B | +4.3% | 69.4% | 29.7% | $4.69B |
| Q1'24 | $21.38B | +2.3% | 69.6% | 29.3% | $3.26B |
Company Information
Symbol
JNJ
Company
Johnson & Johnson
Market Cap
$578.22B
Sector
HEALTHCARE
Next Earnings
Jul 15, 2026
Also Reporting Soon
Companies reporting earnings around the same time as JNJ
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare JNJ with competitors
Side-by-side earnings comparison